HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Infectious Disease
RCT
Oral fosfomycin noninferior to intravenous carbapenems for clinical cure in ESBL-producing Enterobacterales UTIs
Oral fosfomycin shows promise for treating complicated urinary tract infections
This multicenter, open-label, randomized noninferiority trial evaluated 299 adults with complicated UTIs caused by ESBL-producing Enterobact…
Patients with complicated urinary tract infections may be able to switch from IV drugs to oral fosfomycin with similar success rates.
Oct 10, 2026
Infectious Disease
Sys. Review
Beta-lactam/beta-lactamase inhibitor therapy reduces all-cause mortality in multidrug-resistant Gram-negative infections
Combination Therapy Shows Better Outcomes for Gram-Negative Infections
This systematic review and network meta-analysis of 1760 patients found that beta-lactam/beta-lactamase inhibitor therapy significantly redu…
Combining certain antibiotics may lower death rates and reduce kidney damage for patients with multidrug-resistant Gram-negative infections.
Sep 3, 2026
Infectious Disease
Sys. Review
Low antimicrobial resistance in Lawsonella clevelandensis infections suggests susceptibility to penicillins, carbapenems, clindamycin, and metronidazole
Doctors find specific bacteria cause deep abscesses in fat tissue
This narrative review of 27 publications, including 18 clinical cases, examines Lawsonella clevelandensis infections in deep-seated abscesse…
A rare bacterium often hides in deep infections of the breast and abdomen, making it hard to treat without a high index of suspicion.
Frontiers
Aug 19, 2026